Grant: Discovery Grants Program - Individual
University of Alberta
$29,000.00
Chemical tailoring of poly(ethylene oxide)-block-poly(ester) copolymers for drug delivery applications
EF 2013-14
Résumé
The main purpose of this research is to design and develop novel synthetic materials that can adequately solubilize drugs, release them in an appropriate rate and location, and at the same time, are safe for application in humans. Such compounds are expected to mimic the function of biological transport systems: be recognized as self within the body, carry adequate quantities of the drug to its site of action, release their cargo in the vicinity of their cellular and molecular targets and degrade to biocompatible components afterwards. Synthetic biomaterials are advantageous to their biological counterparts due to the ease of structural modifications, stability and safety of administration.In the previous phases of this project, we have developed and protected with patent filings a library of biocompatible and biodegradable polymers with such properties. The copolymers within this library have been utilized to form core/shell structures in nanometer size range, namely polymeric micelles, that were able to encapsulate a number of drugs and drug-able genes, stabilize them in the harsh biological environment, reduce their exposure to healthy cells/tissues and at the same time direct the incorporated drug towards diseased cells. The aim of current proposal is to develop more advanced generations of these polymers and the associated nano-carriers for use in depot and targeted drug delivery. We propose to develop ""intelligent"" materials based on innovative polymers that can sense the presence of internal and/or external triggers (such as temperature, pH, metabolizing enzymes) in the diseased state, change their conformation and (depending on the chemical structure of the material) either make a gel or release the drug in response to those triggers. Such materials are expected to tackle many problems associated with the administration of existing and emerging therapeutics as well as diagnostics, such as low solubility, low stability and low access to the site of action, and significantly enhance their therapeutic benefit and safety upon application in human.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
261196-2013
Name nom
Lavasanifar, Afsaneh
Department département
Pharmacy and Pharmaceutical Science, Faculty of
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Chemical tailoring of poly(ethylene oxide)-block-poly(ester) copolymers for drug delivery applications
Keyword
NSERC
Application summary
The main purpose of this research is to design and develop novel synthetic materials that can adequately solubilize drugs, release them in an appropriate rate and location, and at the same time, are safe for application in humans. Such compounds are expected to mimic the function of biological transport systems: be recognized as self within the body, carry adequate quantities of the drug to its site of action, release their cargo in the vicinity of their cellular and molecular targets and degrade to biocompatible components afterwards. Synthetic biomaterials are advantageous to their biological counterparts due to the ease of structural modifications, stability and safety of administration.In the previous phases of this project, we have developed and protected with patent filings a library of biocompatible and biodegradable polymers with such properties. The copolymers within this library have been utilized to form core/shell structures in nanometer size range, namely polymeric micelles, that were able to encapsulate a number of drugs and drug-able genes, stabilize them in the harsh biological environment, reduce their exposure to healthy cells/tissues and at the same time direct the incorporated drug towards diseased cells. The aim of current proposal is to develop more advanced generations of these polymers and the associated nano-carriers for use in depot and targeted drug delivery. We propose to develop ""intelligent"" materials based on innovative polymers that can sense the presence of internal and/or external triggers (such as temperature, pH, metabolizing enzymes) in the diseased state, change their conformation and (depending on the chemical structure of the material) either make a gel or release the drug in response to those triggers. Such materials are expected to tackle many problems associated with the administration of existing and emerging therapeutics as well as diagnostics, such as low solubility, low stability and low access to the site of action, and significantly enhance their therapeutic benefit and safety upon application in human.